Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. (Q53465653)
Jump to navigation
Jump to search
scientific article published in September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. |
scientific article published in September 2007 |
Statements
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. (English)
William Pao
1 reference
Gregory J Riely
Binsheng Zhao
Tim Akhurst
Daniel T Milton
Erin Moore
Leslie Tyson
Naiyer A Rizvi
Lawrence H Schwartz
Vincent A Miller
1 September 2007
13
17
5150-5155